Landos Biopharma

About:

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.

Website: http://www.landosbiopharma.com/

Twitter/X: LandosBio

Top Investors: Perceptive Advisors, RTW Investments, OUP (Osage University Partners), PBM Capital Group, Helicase Venture

Description:

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.

Total Funding Amount:

$70M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Blacksburg, Virginia, United States

Founded Date:

2017-06-01

Contact Email:

info(AT)landosbiopharma.com

Founders:

Josep Bassaganya-Riera

Number of Employees:

11-50

Last Funding Date:

2019-08-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai